v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows From Operating Activities:    
Net income (loss) $ 169,626 $ (51,728)
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Share-based compensation expense 2,066 4,556
Gain on change in fair value of SAFE and warrant liabilities (5) (3,184)
Loss on change in fair value of the Amended Brookfield Loan 1,800 12,445
Gain/Loss on change in fair value of the equity securities (208,104) 0
Loss on Brookfield SAFE extinguishment 0 6,216
Change in fair value of Convertible Note 0 (42,980)
Gain on change in fair value of PIPE Warrant liability 0 3,400
Gain on partial lease termination 0 (60)
Provisions for losses on trade and other receivables and contract assets, net of recoveries (518) 126
Depreciation of property, plant and equipment 1,901 1,835
Amortization of discount on debt security investment 0 (34)
Non-cash lease expense 510 917
Non-cash recognition of licensing revenue (1,091) (2,214)
Loss from equity method investees, net 17,462 9,867
Loss from disposal of property, plant and equipment 43 0
Unrealized (Gain)/Loss on net foreign exchange (314) 649
Changes in operating assets and liabilities:    
Accounts receivable, net 496 2,334
Contract assets 3,875 11,231
Accrued interest on debt investment 0 (83)
Other assets (1,627) 1,377
Accounts payable and accrued salaries and wages (2,750) (882)
Contract liabilities 5,430 61
Operating lease liabilities 498 (877)
Other liabilities 46 4,213
Net cash used in operating activities (10,656) (42,815)
Cash Flows From Investing Activities:    
Purchase of property, plant and equipment (731) (879)
Purchase of additional LanzaJet equity method investment (3,000) 0
Proceeds from maturity of debt securities 0 12,408
Net cash (used in) provided by investing activities (3,731) 11,529
Cash Flows From Financing Activities:    
Proceeds from issuance of common stock 50,000 15,050
Issuance costs related to preferred stock and PIPE Warrant 0 (1,881)
Settlement of Forward Purchase Agreement (2,000) 0
Issuance costs related to funding (1,859) 0
Partial settlement of the Brookfield Loan 0 (12,500)
Proceeds from PIPE Warrant 0 24,950
Net cash provided by financing activities 46,141 25,619
Effects of currency translation on cash, cash equivalents and restricted cash 98 (425)
Net increase (decrease) in cash, cash equivalents and restricted cash 31,852 (6,092)
Cash, cash equivalents and restricted cash at beginning of period 17,051 45,737
Cash, cash equivalents and restricted cash at end of period 48,903 39,645
Supplemental disclosure of non-cash investing and financing activities:    
Acquisition of property, plant and equipment under accounts payable 32 106
Issuance of the Brookfield Loan 0 6,216
Cashless issuance of equity for Convertible Notes 0 8,132
Non-cash change in lease liability on partial termination 0 13,025
Non-cash change in ROU assets on partial termination $ 0 $ (13,085)